GGrantIndex
Sort

46,585 grants matching heart failure

Role of Renal Lymphatics in Blood Pressure Regulation

$396,459
Brett M Mitchell · Texas A&M University Health Science Ctr · R01 · FY2021 · DK

Role of Renal Lymphatics in Blood Pressure Regulation

$396,459
Brett M Mitchell · Texas A&M University Health Science Ctr · R01 · FY2020 · DK

A multi-site trial to test benefits of adding a personalized risk calculator to an online decision aid for left ventricular assist device

$396,454
Jennifer Blumenthal-Barby · Baylor College Of Medicine · R01 · FY2021 · HS

Intracellular Serpin Regulation of Intestinal Cell Necrosis

$396,441
Gary Arthur Silverman · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK

Multimodality Imaging of Cell Mediated Gene Transfer

$396,417
Stanford University · R01 · FY2005 · HL

Single Cross-Bridge Kinetics in Transgenic Mouse Hearts Expressing FHC Mutations

$396,397
Julian Borejdo · University Of North Texas Hlth Sci Ctr · R01 · FY2012 · HL

Obesity, salt-sensitivity, and the natriuretic peptides

$396,379
Thomas J Wang · Massachusetts General Hospital · R01 · FY2012 · HL

ACE Inhibition and Novel Cardiovascular Risk Factors

$396,359
University Of Florida · R01 · FY2004 · HL

Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence

$396,354
Steven A Webber · Vanderbilt University Medical Center · U01 · FY2018 · AI

Cardiovascular disease (CVD) and the endothelial bone marrow niche: Project 2

$396,317
Matthias Nahrendorf · Massachusetts General Hospital · P01 · FY2019 · HL

Macaque and human models for preclinical development of iPSCs

$396,316
Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL

Novel Mechanisms of Tolerance Resistance

$396,267
Laurence A Turka · Massachusetts General Hospital · R01 · FY2013 · AI

Novel longevity enhancing pathways regulated by mTOR

$396,259
Christian Sell · Drexel University · R01 · FY2022 · AG

Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer

$396,254
Bonnie Ky · University Of Pennsylvania · R01 · FY2022 · HL

Novel Regulation of Beta Andregenic Receptor Function

$396,250
Sathyamangla V Prasad · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · HL

Post-Transplant Inflammatory Response

$396,250
Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · AI

Designing induction therapies to target memory T cells in high risk recipients

$396,250
Anna Valujskikh · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · AI

Novel roles of Fe (2+), 2-oxoglutarate-dependent dioxygenases in cardiac function

$396,250
Liang Xie · Baylor College Of Medicine · R01 · FY2019 · HL

Compartmental PKA and Pathological Cardiac Hypertrophy

$396,250
Xiongwen Chen · Temple Univ Of The Commonwealth · R01 · FY2018 · HL

Regulation of Sarcoplasmic Reticulum Calcium Release in Heart Failure

$396,250
Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2016 · HL

Mitochondrial Damage-Induced Necroptotic Cell Death in SporadicAscending Thoracic Aortic Aneurysms and Dissections

$396,250
Ying H Shen · Baylor College Of Medicine · R01 · FY2019 · HL

Beta adrenergic receptor-dependent regulation of leukocytes in acute cardiac injury

$396,250
Douglas Tilley · Temple Univ Of The Commonwealth · R01 · FY2021 · HL

Targeting GRK2 in the Heart

$396,250
Walter J Koch · Temple Univ Of The Commonwealth · R01 · FY2021 · HL

Designing induction therapies to target memory T cells in high risk recipients

$396,250
Anna Valujskikh · Cleveland Clinic Lerner Com-Cwru · R56 · FY2014 · AI

Post-Transplant Inflammatory Response

$396,250
Robert Fairchild · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · AI